← FDA Drug Approvals (Drugs@FDA)
ONGLYZA
NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2009-07-31
Drug application
- FDA Application #
NDA022350- Application type
- New Drug Application
- Brand name
- ONGLYZA
- Generic name
- Saxagliptin Hydrochloride
- Active ingredients
- SAXAGLIPTIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ASTRAZENECA AB
- First approval
- 2009-07-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown